Literature DB >> 31707344

Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model.

Mahboubeh Tajaldini1, Firooz Samadi1, Ayyoob Khosravi2, Azim Ghasemnejad3, Jahanbakhsh Asadi4.   

Abstract

BACKGROUND: chemotherapy drugs are the common therapy for cancer cells with side effects. Recent studies reported that natural products may contribute to decreasing the side effects of chemotherapy drugs. Here, we aimed to investigate the effects of orange peel extract (OPE) and its main compound; naringin (NR) to protect the side effects of doxorubicin (Dox) in esophageal cancer stem cells (CSCs) derived tumors in vivo.
METHODS: for this purpose, Esophageal cancer cell (YM1) derived spheres were treated in vitro with OPE, NR, Dox, Dox in combination with OPE or NR. The cell viability was assessed by XTT and the apoptosis was measured using Annexin/7-AAD and the cell cycle was also quantified by using PI staining method. The pluripotency related genes expression was carried out using qRT-PCR The protective effects of OPE and NR were evaluated by body weight evaluation and oxidative stress factors: malondialdehyde (MDA), total antioxidant capacity (TAC) and superoxide dismutase (SOD) measurement in xenograft mice tumor model injected with Dox.
RESULTS: ESCC CSCs overexpress SOX2 and OCT4 pluripotency genes. OPE or NR can protect the cellular toxicity of Dox in vitro mainly by decreasing cellular apoptosis of ESCC CSCs however S-phase cell cycle arrest has not been affected significantly. In vivo experiments revealed that the use of Dox simultaneously with OPE or NR not only can reduce the tumor size but also the body weight of the treated nude mice were maintained in comparison to Dox alone. In contrast to Dox alone, Dox in combination with OPE or NR showed less systemic toxicity and decreased oxidative stress fraction circulation, however, OPE seemed as more protective.
CONCLUSION: The results suggest that these natural compounds can be used as adjuvant therapy to lower systemic toxicity of chemotherapeutic agents like DOX in ESCC cancer stem cells treatment.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cancer stem cell; Doxorubicin; Esophageal squamous cell carcinoma; Orange; peel extract

Mesh:

Substances:

Year:  2019        PMID: 31707344     DOI: 10.1016/j.biopha.2019.109594

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  16 in total

1.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 2.  Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.

Authors:  Marek Samec; Alena Liskova; Lenka Koklesova; Sandra Mersakova; Jan Strnadel; Karol Kajo; Martin Pec; Kevin Zhai; Karel Smejkal; Sepideh Mirzaei; Kiavash Hushmandi; Milad Ashrafizadeh; Luciano Saso; Aranka Brockmueller; Mehdi Shakibaei; Dietrich Büsselberg; Peter Kubatka
Journal:  Cancers (Basel)       Date:  2021-01-03       Impact factor: 6.639

3.  A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.

Authors:  Maryam Ghanbari-Movahed; Gloria Jackson; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

4.  The DNA methylation-regulated MCTP1 activates the drug-resistance of esophageal cancer cells.

Authors:  Lingsuo Kong; Wan Yang; Lanren Chen; Liting Qian
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

Review 5.  Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review.

Authors:  Luchang Cao; Xinmiao Wang; Guanghui Zhu; Shixin Li; Heping Wang; Jingyuan Wu; Taicheng Lu; Jie Li
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

6.  Antioxidant, Anticancer, and PXR-Dependent CYP3A4 Attributes of Schweinfurthia papilionacea (Burm.f.) Boiss., Tricholepis glaberrima DC. and Viola stocksii Boiss.

Authors:  Amir Shahbaz; Javed Iqbal; Banzeer Ahsan Abbasi; Wasim Akhtar; Iram Fatima; Syeda Anber Zahra; Sobia Kanwal; Javad Sharifi-Rad; Hassan Sher; Tariq Mahmood; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-02-16       Impact factor: 6.543

Review 7.  Advances and challenges in the treatment of esophageal cancer.

Authors:  Shiming He; Jian Xu; Xiujun Liu; Yongsu Zhen
Journal:  Acta Pharm Sin B       Date:  2021-03-09       Impact factor: 11.413

8.  Aprepitant Promotes Caspase-Dependent Apoptotic Cell Death and G2/M Arrest through PI3K/Akt/NF-κB Axis in Cancer Stem-Like Esophageal Squamous Cell Carcinoma Spheres.

Authors:  Hossein Javid; Amir R Afshari; Farnaz Zahedi Avval; Jahanbakhsh Asadi; Seyed Isaac Hashemy
Journal:  Biomed Res Int       Date:  2021-12-09       Impact factor: 3.411

Review 9.  Valorization of Citrus Co-Products: Recovery of Bioactive Compounds and Application in Meat and Meat Products.

Authors:  Gema Nieto; Juana Fernández-López; José A Pérez-Álvarez; Rocío Peñalver; Gaspar Ros-Berruezo; Manuel Viuda-Martos
Journal:  Plants (Basel)       Date:  2021-05-26

Review 10.  ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer.

Authors:  Gan Huang; Shu-Ting Pan
Journal:  Oxid Med Cell Longev       Date:  2020-07-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.